Psilocybin's acute and persistent brain effects: a precision imaging drug trial

Subha Subramanian1, Travis Rick Renau2, Demetrius Perry2

  • 1Department of Psychiatry, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, 02215, USA. ssubram5@bidmc.harvard.edu.

Scientific Data
|June 5, 2025
PubMed
Summary

Precision functional mapping reveals acute and persistent effects of psilocybin (PSIL) and methylphenidate (MTP) on brain networks. This study provides a unique dataset for neuroscientists investigating psychedelic and stimulant impacts on brain function.